Blog

view:  full / summary

Musings on Anti-Xa Activity Levels

Posted by gulseth.michael on March 8, 2017 at 1:30 PM Comments comments (0)

 

Recently, there was a good article in AJHP on dealing with transitions from oral Xa inhibitors to heparin. You can read it at AJHP 2016; 73:2037-41

This has piqued a lot of my interest in this subject since we actively use novel drug levels like dabigatran, rivaroxaban, and apixaban levels. We have published on this in the past. See: http://www.ajhp.org/content/early/2017/02/21/ajhp160168

 

Recently, I have been seeing a lack of understanding on how to hand...

Read Full Post »

2017 ISMP Antithrombotic Therapy Self-Assessment

Posted by gulseth.michael on February 17, 2017 at 11:30 AM Comments comments (0)

Hello all!

Excited to announce the realease of the new, 2017 ISMP Medication Safety Self-Assessment for Antithrombotic Therapy.  I would strongly encourage all practitioners who work in health-systems to review these new guidelines so we can keep our patients safe.  They do cover direct acting oral anticoagulants.

http://www.ismp.org/selfassessments/Antithrombotic/2017/Default.aspx

Thank you, as always, to the leadershp shown by ISMP!

Michael P. Gusleth, Phar...

Read Full Post »

Rss_feed